Avricore Health Inc (AVCR) 시세

fomo momo hodl the biz is delivering

https://money.tmx.com/en/quote/AVCR/news/5178511385005514/Avricore_Health_Makes_the_Grade_on_2023_TSX_Venture_50

AVCR top 50

Avricore Health Corporate Update - Earnings Advisory 2022 and 2023 Objectives
https://money.tmx.com/en/quote/AVCR/news/7046287989064865/Avricore_Health_Corporate_Update_Earnings_Advisory_2022_and_2023_Objectives

https://www.proactiveinvestors.com/companies/news/1000418/avricore-health-sees-3q-revenue-soar-by-662-as-it-successfully-scales-its-healthtab-network-1000418.html

Avricore Health sees 3Q revenue soar by 662% as it successfully scales its HealthTab network

Break out, 450 installed Abbott's, major national pharma Shoppers Drug Mart

Thanks...not showing up anywhere else.

https://finance.yahoo.com/news/avricore-health-healthtab-enable-real-123000521.html

I see no news...

NEWS - running

$AVCRF Tier Change- OTCQB to Pink Current

They changed the name b cause they don't sell pharmaceuticals anymore I guess? New name should be 'Avricore Worthless Paper'.

NUVPF changed to AVCRF:

http://otce.finra.org/DLSymbolNameChanges

NUVPF: Effective Nov. 5,2018 VANC Pharmaceuticals Inc. will change to Avricore Health Inc.

http://otce.finra.org/DLSymbolNameChanges

Bleeding out back to $.10 now. Shocker.

This pathetic excuse for a company should have announced thst the day after they bought Corozon. But no. They chose to burn cash and bloat the shsre structure for 6 months instead. Maybe this can bounce back to $.20 so I can get out even. Probably not though!

VANC Contracts with Lampyon to Extend its Corozon Educational and Ecommerce Platform with Medical Cannabis Education and New Sales Capabilities

https://finance.yahoo.com/news/philippe-ugnat-llb-joins-vanc-003239638.html

Yup. These guys give the TSX.V a bad name. I can't wait to be finished scaling out of this garbage company. Sold 20k today. Ready to dump another 20k again on each uptick til im out for good. Can't wait.

Exactly. Let us have our freedom without picking our pockets any more. Hope they enjoyed their mojitos on our dime.

This company has no regard for shareholders whatsoever. If you want to make money on this POS then you have to wait until they crush the stock down to the basement to fill a PP, then flip it as they pump it up to keep the PP holders from screaming bloody murder. These guys a re so slow to do anything, they waited 6 months to announce they are integrating cannabis into their point of care modules or whatever, it's sad. I can;t wait for this to spike up a little higher so I can get the heck out with the rest of my shares. Terrible management imho.

Finally some movement so I can take some off the table here, thank goodness.

Cannabis flying, VANC asleep at the wheel. What else is new? SMH

It is literally shocking how incompetent the mgmt of this company is that they cannot capitalize in this environment in Canada. PATHETIC VANC

Im down like $20k on this nuvPOS... SMH

Back to $.10 range, maybe one day mgmt will get their act together. These guys are just wasting time and shareholder money every day they don't update on their plans with EMH... Ridiculous!

There is no reason we should be down here sub $.20 given the partnership with EMH, hopefully now with legalization on deck in Canada these guys are ready to hit the gas. It shouldn't take much, just a few updates on the Emerald partnership and VANC should be pushing back up hard on this SS. Fingers crossed.

The time is past due for a gameplan here. I’ve held these shares at a loss long enough. Hopefully this will shed some light on some profitable developments. :)

Vanc Pharma hires Transcend for IR services

2018-08-23 16:42 ET - News Release


Mr. Bob Rai reports

Vanc Pharmaceuticals Inc. has entered into a consulting agreement with Transcend Capital Inc. to develop and implement an investor relations program for the company. Transcend, with offices in Vancouver, B.C., is a full-service investor relations firm that assists small and mid-cap public companies with market awareness campaigns, and helps these companies gain valued industry exposure through an extensive network of retail and institutional clients. Etienne Moshevich is the sole owner of Transcend.

Transcend will provide comprehensive investor relations services to the company for an initial period of 24 months for an aggregate fee of $150,000 plus applicable taxes. Transcend and its directors, officers and employees are shareholders of the company, collectively holding approximately 3.5 per cent of the issued and outstanding common shares of the company.

The investor relations consulting agreement is subject to the approval of the TSX Venture Exchange.

About Vanc Pharmaceuticals Inc.

Vanc Pharmaceuticals aims to become the partner of choice for forward-thinking pharmacies across Canada. With an established sales force, distribution network, and team of highly experienced professionals in pharmacy, point-of-care testing and health technology, Vanc is growing beyond generics to provide pharmacists with innovative, value-added products and services to expand their scope of practice and support their evolving role as front-line healthcare providers.

We seek Safe Harbor.

© 2018 Canjex Publishing Ltd. All rights reserved.
https://www.stockwatch.com/News/Item.aspx?bid=Z-C%3aVANC-2650215&symbol=VANC®ion=C

Emerald Health Therapeutics Inc.
Exchange: TSXV Exchange
$4.65 Aug 23, 2018, 4:00 PM EDT 0.35 (8.14%)Vol: 5,348,395

Boom another huge day for big bad EMH... Quiet little TSX VANC waiting for the signal from big bro EMH, tick tock NUVPF, hopefully soon we have timely and significant updates. Gltua here with VANC/NUVPF and EMH/EMHTF.

Another great day for NUVPF partner/holder EMHTF +15% today back over $3 USD... lets go VANC bring the updates on cannabis partnership with EMHTF let's go!

Still holding...ready for some good news.

Finally some relief. EMHTF moving North and bringing little bro NUVPF with.

$.09 you gotta be kidding me NUVPF this is pathetic.

Blah.. Im getting sick of this POS, mgmt here is moving too damn slow!

Yes hopefully it will be quick, the drop has been on low volume and we have not heard anything about the partnership with EMH for the entire time it's been dropping... Any positive news on the partnership and this should snap back hard imo. Fingers crossed NUVPF

Can’t wait to hear something. Maybe in the next week or two? Let’s get things going.

PP closed, time to move back north hopefully they have some developments with EMH coming soon

Vanc Pharmaceuticals 5,327,335-share private placement

2018-07-31 16:47 ET - Private Placement

The TSX Venture Exchange has accepted for filing documentation with respect to a non-brokered private placement announced July 11, 2018.

Number of shares: 5,327,335 shares

Purchase price: 15 cents per share

Warrants: 5,327,335 share purchase warrants to purchase 5,327,335 shares

Warrant initial exercise price: 33 cents

Warrant term to expiry: two years

Number of placees: 16 placees

Finders' fees: PI Financial Corp., $4,320 cash and 28,800 warrants; First Republic Capital Corp., $9,000 cash and 60,000 warrants

Finder's warrant initial exercise price: 33 cents

Finder's warrant term to expiry: may purchase one common share for up to two years from closing at 33 cents per common share

Note that in certain circumstances the exchange may later extend the expiry date of the warrants if they are less than the maximum permitted term.

July 30, 2018
Item 3 News Release
The news release was disseminated on July 30, 2018 by way of the facilities of Stockwatch. Copies were also filed on SEDAR with the British Columbia Securities Commission and the Alberta Securities Commission.
Item 4 Summary of Material Change
Item 5 Full Description of Material Change
5.1 Full Description of Material Change
The Company announced that further to its news release dated July 11, 2018, it has closed a non-brokered private placement of 5,327,335 units (“Units”) of the Company at a price of $0.15 per Unit for gross proceeds of approximately CDN$799,100 (the “Offering”).
Each Unit consists of one (1) common share of the Company (a “Common Share”) and one (1) share purchase warrant (a “Warrant”). Each Warrant entitles the holder thereof to purchase one Common Share for a period of two (2) years following the closing date at a price of $0.33 per Common Share.
The securities issued pursuant to the Offering are subject to a four (4) month hold period, which will expire on December 1st, 2018.
The Company paid aggregate finder’s fees of CDN$13,320 (6% on $222,000) and issued 88,800 finder’s warrants (6% on 1,480,000 Units). Each finder’s warrant entitles the finder to purchase one (1) Common Share for a period of two (2) years following the closing date at a price of $0.33 per Common Share.
Proceeds from the Offering are planned to be used by VANC for corporate overhead and working capital.
Completion of the Offering is subject to all required regulatory approvals, including final acceptance by the TSX Venture Exchange.
https://www.stockwatch.com/News/Item.aspx?bid=Z-C%3aVANC-2640065&symbol=VANC®ion=C

Still holdin amigo lets go!

Agreed. Im adding down here, I think this has been forced down so they can do another PP here while VANC is still under the radar and SP is in the gutter. All it needs is some confirmarion of pharmacy cannabis distribution and NUVPF should be headed to $1 land while EMH heads toward $10. Jmho

Wish it weren't so. But I'm red here sooo, I kinda want to move up bro. Fact is, pps has been taken down over the last couple of months on relatively low volume. Any kind of distribution/sales news should take us back to .20+ imo. $NUVPF

NUVPF it is ridiculous how hard it is to get my buys executed here. I am forced to pay way above the ask if I want a fill. Smh

I was just looking at SEDAR and on July 11 VANC announced a private placement for $1M @ $0.15 per ubit CAD... Probably explains why the price has been depressed while they complete the PP. I wouldn't surprise me if EMH takes down a large chunk of the PP.

Emerald Health Therapeutics (Puresun Farms) just got its sales license...would not be surprised to hear some good news here soon. $NUVPF

NUVPF will have its day in the sun, Im sure.

That's very interesting, I was in ATTB* when it ran to $2 back in 2014, before it became bloated, (post #22 all time actually https://investorshub.advfn.com/boards/read_msg.aspx?message_id=95700527) so Im familiar with nrthrn vine. VANC has real promise, largely buttressed by its relatively unscathed SS. It would be a good acquisition target for EMH especially if Canada commits to pharmacy distribution of THC derivatives. Time will tell my friend. GL

Tick tock my friends. :) $NUVPF

Emh just bought out northern vine wonder if nuvpf is next that would be whole distribution system !

As much as I am disappointed by the performance here, I look around and see sector darlings (i.e. EMH) also getting beaten down, and so I see perhaps there is a silver lining to this and I may add another lot to my pile here in the next few weeks in this depressed price range. When EMH is back over $5 then VANC should also be dramatically higher at that time as well, perhaps testing new highs. I don't know what the time frame on that is, but maybe close to 2019. Whay do you think?

Yeah I think ur probably right there.

Looks like they owed a 6k from a old news release .. I think imho